New insights into malignant cell survival mechanisms in medulloblastoma

Frank Eckerdt1, Stewart Goldman2, Leonidas C Platanias3

  • 1Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, 60611.

Cancer Cell & Microenvironment
|June 23, 2015
PubMed

Insights

Targeting mTOR in cancer therapy can trigger compensatory feedback loops. Inhibition of mTORC1 by rapamycin activates Mnk2, promoting protein translation and cell transformation, posing a challenge for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Homeostasis

Background:

  • mRNA translation and protein synthesis are critical for cell metabolism and homeostasis.
  • Cellular homeostasis perturbations activate negative feedback loops, which can be exploited by cancer cells as escape mechanisms.
  • The mammalian target of rapamycin (mTOR) pathway is a key regulator of translation and protein synthesis, making it a target for cancer therapy.

Purpose of the Study:

  • To discuss the implications of mTOR inhibition on negative feedback regulation in cancer.
  • To explore the role of mitogen-activated protein (MAP) kinase-interacting kinase 2 (Mnk2) in mediating feedback loops.
  • To understand how these mechanisms challenge targeted cancer therapy.

Main Methods:

  • Selective inhibition of mTORC1 using rapamycin or its analogs in medulloblastoma cells.
  • Analysis of eukaryotic translation initiation factor 4E (eIF4E) phosphorylation at serine-209.
  • Investigation of Mnk2's role in mediating eIF4E phosphorylation independently of MAPKs.

Main Results:

  • Selective mTORC1 inhibition leads to phosphorylation of eIF4E on serine-209.
  • This phosphorylation event is associated with induced protein translation and cell transformation.
  • Mnk2 mediates this effect independently of conventional MAPK activators.

Conclusions:

  • mTOR inhibition can activate compensatory feedback mechanisms involving Mnk2.
  • These feedback loops promote protein translation and cell transformation, potentially conferring resistance to cancer therapy.
  • Understanding these pathways is crucial for developing more effective cancer treatments targeting mTOR.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K